Parameter
| Biomarker | CUBN / MPO | Full name | Cubilin Protein / Myeloperoxidase Protein ratio | Molecular Type | Protein (ratio) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis & prognosis (combined ratio) |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Urine (immunoblot, ELISA) | ||
| Pathobiological Mechanisms | Low CUBN/MPO ratio predicts high-grade BC recurrence & progression risk | ||||
| Clinical Availability Status | Research verification stage (n = 30 pilot) | ||||
| Notes and Dynamics | Ratio-based prognostic index; large-scale validation needed to avoid sampling bias | ||||